Accuracy of Continuous Glucose Monitors During the Perioperative Period in Youth With Type 1 Diabetes

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age2-26
SponsorUniversity of Colorado, Denver

About this trial

This study is assessing the accuracy of continuous glucose monitors during surgical procedures requiring anesthesia.

Eligibility criteria

Qualifiers

Participants will be 2 to 26 years of age at the time of enrollment.

Participants will have a diagnosis of type 1 diabetes on insulin therapy and requiring close glucose monitoring during the hospitalization and the perioperative period.

Participant currently wearing a continuous glucose monitor (for example: Dexcom G6 or G7; Freestyle Libre 2, 2 Plus, or 3; Medtronic Guardian 3 or 4; or future sensors as they become available) for home diabetes management and willing to share personal CGM data with the BDC clinical CGM account.

Disqualifiers

Pregnancy.

Currently using hydroxyurea.

A condition that the investigator determines would prevent the patient from participation.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

120 Participants
are grouped into 1 trial group

Sponsors and collaborators